| Literature DB >> 35283272 |
Zongyang Lu1, Siting He2, Jian Jiang3, Ling Zhuang2, Yan Wang4, Guang Yang5, Xiaoyu Jiang4, Yanhong Nie4, Jiqiang Fu4, Xiaotong Zhang4, Yong Lu4, Xinyan Bian4, Hung-Chun Chang3, Zhiqi Xiong4, Xingxu Huang6, Zhen Liu7, Qiang Sun8.
Abstract
Presynaptic syntaxin binding protein 1 (STXBP1) is essential for neurotransmitter release. Heterozygous mutations in this protein cause STXBP1 encephalopathy (STXBP1-E), which is characterized by intellectual disabilities and epilepsies. Since nonhuman primates closely resemble humans, monkey models may advance studies on the pathogenesis and therapeutic treatments of STXBP1-E. We generated cynomolgus monkeys carrying STXBP1 (R292H) mutation through base editing of in vitro fertilized embryos to mimic a clinical condition. The newborn STXBP1-edited monkeys exhibited focal epilepsy, and the animal that survived beyond the first week postpartum presented typical EEG phenotypes. Biochemical analysis of brain biopsy samples showed reduced levels of STXBP1 (MUNC18-1) and SNARE complex proteins. Single-cell sequencing identified one specific cell cluster that may contribute to encephalopathy. Thus, our case report shows that base-edited STXBP1 mutant monkeys are a good animal model for STXBP1-E, and that a base-editing approach is useful for generating primate models of human genetic disorders.Entities:
Keywords: A3A; EEG; STXBP1; base editor; encephalopathy; nonhuman primate
Mesh:
Substances:
Year: 2022 PMID: 35283272 PMCID: PMC9171284 DOI: 10.1016/j.ymthe.2022.03.001
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 12.910